Alligator Bioscience announced that preclinical data on its agonist anti-CD40 antibody mitazalimab has been published in the scientific journal Cancer Immunology, Immunotherapy.
The published data show that mitazalimab activates dendritic cells and tumor-reactive T cells resulting in enhanced anti-tumor efficacy in combination with a model cancer vaccine.
- Read more about Alligators mitazalimab shown to enhance cancer vaccine
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/alligators-mitazalimab-shown-to-enhance-cancer-vaccine
No comments:
Post a Comment